Daniel Shoemaker Net Worth & Insider Trades

Daniel Shoemaker - Chief Scientific Officer, Fate Therapeutics Inc

As of March 9, 2021

What is Daniel Shoemaker's Net Worth?

The current estimated net worth of Fate Therapeutics Inc's Chief Scientific Officer, Daniel Shoemaker, is estimated to be about $9.6M . Daniel Shoemaker owns about 73,020 units of Fate Therapeutics Inc common stock. In the last 7 years at Fate Therapeutics Inc, Daniel Shoemaker has sold an estimated value of $6.71M worth.

What is Daniel Shoemaker's Past Insider Trading?

Daniel Shoemaker's largest purchase order was 25,000 units , worth over $72.5K on January 2, 2020. Daniel Shoemaker's largest sale order was 25,000 units , worth over $2.04M on March 9, 2021. In total, Daniel Shoemaker has made about 19 transactions over 7 years of their time at Fate Therapeutics Inc. Daniel Shoemaker usually trades in January, with the busiest year in 2019 and 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Daniel Shoemaker's Salary in 2020?

As Chief Scientific Officer of Fate Therapeutics Inc, Daniel Shoemaker has a total base salary of $390,000 . Daniel Shoemaker received compensation valued at about $2,459,097 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of stock awards of $549,750 , option awards of $1,324,347 , other earnings, plans or compensations of $195,000 , and

What is Daniel Shoemaker's' Mailing Address?

  • Mailing address is C/o Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121 CA

Fate Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
J. Scott Wolchko 2020 $570,000 - $1,451,340 $3,222,577 $356,250 - $5,600,167
J. Scott Wolchko 2019 $540,000 - $4,137,500 $5,732,955 $310,500 - $10,720,955
J. Scott Wolchko 2018 $516,000 - - $2,756,998 $258,000 - $3,530,998
Edward J. Dulac III 2020 $142,500 $137,917 $1,420,800 $3,786,529 $75,833 $120,000 $5,683,579
Bahram Valamehr, Ph.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Bahram Valamehr, Ph.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Bahram Valamehr, Ph.D. 2018 $321,865 - - $2,138,235 $117,250 - $2,577,350
Cindy R. Tahl, J.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Cindy R. Tahl, J.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Cindy R. Tahl, J.D. 2018 $350,000 - - $906,465 $122,500 - $1,378,965
Daniel D. Shoemaker, Ph.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Daniel D. Shoemaker, Ph.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Daniel D. Shoemaker, Ph.D. 2018 $365,000 - - $842,338 $127,750 - $1,335,088
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1434316/000119312521124699/d85377ddef14a.htm

What are Fate Therapeutics Inc's Past Insider Trades?

Fate Therapeutics Inc's most recent insider trade came on July 25, 2022 by Scott Wolchko who sold 36,246 units worth $1.19M . In the last 9 years, insiders at Fate Therapeutics Inc have sold an estimated value of $126.38M and bought an estimated value of $170.91M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Scott Wolchko, President and CEO,  Cindy Tahl, General Counsel and Secretary,  and Amir Nashat, Director .

FATE THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1